Collective Family Office’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $376K | Buy |
142,380
+38,210
| +37% | +$101K | 0.1% | 124 |
|
|
2025
Q1 | $314K | Buy |
104,170
+15,340
| +17% | +$46.2K | 0.08% | 129 |
|
|
2024
Q4 | $227K | Buy |
88,830
+9,467
| +12% | +$24.2K | 0.06% | 152 |
|
|
2024
Q3 | $295K | Buy |
79,363
+9,008
| +13% | +$33.5K | 0.08% | 148 |
|
|
2024
Q2 | $445K | Buy |
+70,355
| New | +$445K | 0.13% | 117 |
|